HIV-AIDS Diagnostics Market - Global Industry Analysis

Table Of Content

Methodology

Free Analysis

HIV-AIDS is a human immune deficiency syndrome, which is caused by the human immunodeficiency virus. This leads to a weak immune system where the body loses its ability to fight against harmful microorganisms. HIV-AIDS spreads through infected mothers, unprotected sex with an infected person, sharing needles with an infected person, and infected blood transfusions. Various symptoms of HIV-AIDS are headaches, muscle aches, swollen glands, etc. HIV-AIDS diagnostics help in early detection and better treatment along with effective patient care, which prevents health degradation and helps in maintaining one’s quality of life. There is no permanent cure available in the market for HIV-AIDS treatment, but there are few treatments available in the market that reduce the disease’ mortality.

The various factors contributing to the global HIV-AIDS diagnostics market are increasing HIV-AIDS prevalence and rising awareness among people. As per UNAIDS, there were around 36.9 million people globally living with HIV-AIDS in 2017 and around 1.8 million people globally get affected with HIV-AIDS annually. Furthermore, an increase in government and non-government initiatives to raise awareness among people is also expected to promote the HIV-AIDS market globally in the years ahead. Moreover, increasing demand for blood transfusion will lead to increased incidences of HIV-AIDS infections. Technological advancements coupled with a growing number of research and development activities for effective diagnostics techniques are expected to create ample opportunities in the HIV-AIDS diagnostics market globally in the future. However, high costs of advanced diagnostics may hinder the global HIV-AIDS diagnostics market over the forecast time period.

The global HIV-AIDS diagnostics market is categorized into product type, test type, and end-user. By product type, the HIV-AIDS diagnostics market is fragmented into instruments, kits and reagents, and others. The kits and reagents segment is expected to hold the largest market share over the forecast time period. Based on test type, the HIV-AIDS diagnostics market is fragmented into ELISA, nucleic acid tests, rapid tests (POC), and others. ELISA is expected to hold the largest market share in the future. Based on end-user, the HIV-AIDS diagnostics market is fragmented into private diagnostics laboratories, hospitals, research institutes, academic, and others. Private diagnostic laboratories are likely to hold the major market share over the estimated timeline.

By region, Europe is expected to hold the major share of the HIV-AIDS diagnostics market globally in the future. The Asia Pacific is expected to be the fastest developing region in this market in the future, owing to the presence of emerging economies, such as India and China.

Some major market players of the HIV-AIDS diagnostics market include Alere, OraSure Technologies, Inc., Bio-Rad Laboratories, Siemens Healthineers, Abbott Laboratories, Hologic, Inc., Chembio Diagnostic Systems, and F. Hoffmann-La Roche Ltd.